Drug Profile
Research programme: Islet Neogenesis Therapy for transplantation - Transition Therapeutics
Alternative Names: I.N.T.(TM) for transplantation; I.N.T.(TM) for transplantation research programme - Transition Therapeutics; Islet Neogenesis Therapy for transplantation research programme - Transition TherapeuticsLatest Information Update: 24 Aug 2010
Price :
$50
*
At a glance
- Originator Transition Therapeutics
- Class Growth factors
- Mechanism of Action Somatotropin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Type 1 diabetes mellitus
Most Recent Events
- 26 Oct 2004 Preclinical trials in Type-1 diabetes mellitus in Canada (unspecified route)